These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1015 related items for PubMed ID: 24650170

  • 1. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.
    Kiely P, Margaritis AR, Seed CR, Yang H, Australian Red Cross Blood Service NAT Study Group.
    Transfusion; 2014 Aug; 54(8):2084-91. PubMed ID: 24650170
    [Abstract] [Full Text] [Related]

  • 2. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
    Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY.
    Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101
    [Abstract] [Full Text] [Related]

  • 3. Blood donor screening in the Netherlands: Universal anti-HBc screening in combination with HBV nucleic acid amplification testing may allow discontinuation of hepatitis B virus antigen testing.
    van de Laar TJ, Hogema BM, Molenaar-de Backer MW, Marijt-van der Kreek T, Zaaijer HL.
    Transfusion; 2021 Jul; 61(7):2116-2124. PubMed ID: 33899233
    [Abstract] [Full Text] [Related]

  • 4. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
    Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP, REDS Study Group.
    Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
    [Abstract] [Full Text] [Related]

  • 5. Hepatitis B virus DNA viral load determination in hepatitis B surface antigen-negative Swiss blood donors.
    Stolz M, Tinguely C, Fontana S, Niederhauser C.
    Transfusion; 2014 Nov; 54(11):2961-7. PubMed ID: 24805974
    [Abstract] [Full Text] [Related]

  • 6. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply.
    Zheng X, Ye X, Du P, Zeng J, Zhu W, Yang B, Li C, Allain JP.
    Transfusion; 2015 Apr; 55(4):890-7. PubMed ID: 25363504
    [Abstract] [Full Text] [Related]

  • 7. The yield of universal antibody to hepatitis B core antigen donor screening in the Netherlands, a hepatitis B virus low-endemic country.
    van de Laar TJ, Marijt-van der Kreek T, Molenaar-de Backer MW, Hogema BM, Zaaijer HL.
    Transfusion; 2015 Jun; 55(6):1206-13. PubMed ID: 25494685
    [Abstract] [Full Text] [Related]

  • 8. Occult hepatitis B virus infection.
    Allain JP.
    Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
    [Abstract] [Full Text] [Related]

  • 9. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
    Busch MP.
    Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
    [Abstract] [Full Text] [Related]

  • 10. Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations.
    Martin LA, Stramer SL, Kuhns MC, Schlauder GG.
    Transfusion; 2012 Oct; 52(10):2201-8. PubMed ID: 22321072
    [Abstract] [Full Text] [Related]

  • 11. Occult hepatitis B virus infection: implications in transfusion.
    Allain JP.
    Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
    [Abstract] [Full Text] [Related]

  • 12. Blood donor testing for hepatitis B virus in the United States: is there a case for continuation of hepatitis B surface antigen detection?
    Dodd RY, Nguyen ML, Krysztof DE, Notari EP, Stramer SL.
    Transfusion; 2018 Sep; 58(9):2166-2170. PubMed ID: 30144082
    [Abstract] [Full Text] [Related]

  • 13. Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety?
    Stramer SL, Notari EP, Krysztof DE, Dodd RY.
    Transfusion; 2013 Oct; 53(10 Pt 2):2449-58. PubMed ID: 23607261
    [Abstract] [Full Text] [Related]

  • 14. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test.
    Kleinman SH, Strong DM, Tegtmeier GG, Holland PV, Gorlin JB, Cousins C, Chiacchierini RP, Pietrelli LA.
    Transfusion; 2005 Aug; 45(8):1247-57. PubMed ID: 16078909
    [Abstract] [Full Text] [Related]

  • 15. Detection of an acute asymptomatic HBsAg negative hepatitis B virus infection in a blood donor by HBV DNA testing.
    Weber B, Mühlbacher A, Melchior W.
    J Clin Virol; 2005 Jan; 32(1):67-70. PubMed ID: 15572009
    [Abstract] [Full Text] [Related]

  • 16. Sensitivity of hepatitis B virus DNA transcription-mediated amplification testing in hepatitis B surface antigen-positive blood donations.
    Bouchardeau F, Girault A, Razer A, Servant-Delmas A, Mercier M, Laperche S.
    Transfusion; 2006 Dec; 46(12):2047-52. PubMed ID: 17176315
    [Abstract] [Full Text] [Related]

  • 17. Occult hepatitis B infection and transfusion-transmission risk.
    Candotti D, Boizeau L, Laperche S.
    Transfus Clin Biol; 2017 Sep; 24(3):189-195. PubMed ID: 28673499
    [Abstract] [Full Text] [Related]

  • 18. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E.
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [Abstract] [Full Text] [Related]

  • 19. Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China.
    Ye X, Li T, Xu X, Du P, Zeng J, Zhu W, Yang B, Li C, Allain JP.
    Blood Transfus; 2017 Jan; 15(1):6-12. PubMed ID: 27416568
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain.
    González R, Torres P, Castro E, Barbolla L, Candotti D, Koppelman M, Zaaijer HL, Lelie N, Allain JP, Echevarría JM.
    Transfusion; 2010 Jan; 50(1):221-30. PubMed ID: 19682332
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.